SWK Holdings Corp
NASDAQ:SWKH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
SWK Holdings Corp
Operating Expenses
SWK Holdings Corp
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SWK Holdings Corp
NASDAQ:SWKH
|
Operating Expenses
-$15.4m
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
-1%
|
|
|
LM Funding America Inc
NASDAQ:LMFA
|
Operating Expenses
-$14.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-17%
|
|
|
A-Mark Precious Metals Inc
NASDAQ:AMRK
|
Operating Expenses
-$194.1m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-47%
|
CAGR 10-Years
-26%
|
|
|
S
|
Standard Premium Finance Holdings Inc
OTC:SPFX
|
Operating Expenses
-$6.4m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
SUI Group Holdings Ltd
NASDAQ:SUIG
|
Operating Expenses
-$11.5m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-34%
|
|
SWK Holdings Corp
Glance View
SWK Holdings Corp. is engaged in the business of financial and asset management in the field of pharmaceutical. The company is headquartered in Dallas, Texas and currently employs 35 full-time employees. The firm is focused on providing various capital solutions to a range of life science companies, institutions and inventors. The firm operates through two segments: Finance Receivables and Pharmaceutical Development. Its Finance Receivables segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. In addition, through its wholly owned subsidiary, SWK Advisors LLC, it provides non-discretionary investment advisory services to institutional clients in separately managed accounts to similarly invest in life science finance. Through its subsidiary, Enteris BioPharma, Inc., its Pharmaceutical Development segment offers formulation solutions built around its oral drug delivery technology, the Peptelligence platform.
See Also
What is SWK Holdings Corp's Operating Expenses?
Operating Expenses
-15.4m
USD
Based on the financial report for Dec 31, 2025, SWK Holdings Corp's Operating Expenses amounts to -15.4m USD.
What is SWK Holdings Corp's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-1%
Over the last year, the Operating Expenses growth was 45%. The average annual Operating Expenses growth rates for SWK Holdings Corp have been 16% over the past three years , 10% over the past five years , and -1% over the past ten years .
